Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,525 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cystometric findings in mice lacking muscarinic M2 or M3 receptors.
Igawa Y, Zhang X, Nishizawa O, Umeda M, Iwata A, Taketo MM, Manabe T, Matsui M, Andersson KE. Igawa Y, et al. Among authors: umeda m. J Urol. 2004 Dec;172(6 Pt 1):2460-4. doi: 10.1097/01.ju.0000138054.77785.4a. J Urol. 2004. PMID: 15538291
Discovery of novel and selective IKK-beta serine-threonine protein kinase inhibitors. Part 1.
Murata T, Shimada M, Sakakibara S, Yoshino T, Kadono H, Masuda T, Shimazaki M, Shintani T, Fuchikami K, Sakai K, Inbe H, Takeshita K, Niki T, Umeda M, Bacon KB, Ziegelbauer KB, Lowinger TB. Murata T, et al. Among authors: umeda m. Bioorg Med Chem Lett. 2003 Mar 10;13(5):913-8. doi: 10.1016/s0960-894x(02)01046-6. Bioorg Med Chem Lett. 2003. PMID: 12617920
The 2023 revised diagnostic criteria for IgG4-related dacryoadenitis and sialadenitis.
Kanda M, Nagahata K, Moriyama M, Takano KI, Kamekura R, Yoshifuji H, Tsuboi H, Yamamoto M, Umehara H, Umeda M, Sakamoto M, Maehara T, Inoue Y, Kubo S, Himi T, Origuchi T, Masaki Y, Mimori T, Dobashi H, Tanaka Y, Nakamura S, Takahashi H. Kanda M, et al. Among authors: umeda m. Mod Rheumatol. 2024 Oct 23:roae096. doi: 10.1093/mr/roae096. Online ahead of print. Mod Rheumatol. 2024. PMID: 39441008
Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study.
Ueno M, Takeda H, Takai A, Morimura H, Nishijima N, Iwamoto S, Okuyama S, Umeda M, Seta T, Ikeda A, Goto T, Miyamoto S, Kayahara T, Uenoyama Y, Matsumura K, Nakano S, Mishima M, Inuzuka T, Eso Y, Takahashi K, Marusawa H, Osaki Y, Hatano E, Seno H. Ueno M, et al. Among authors: umeda m. J Gastroenterol. 2024 Dec;59(12):1119. doi: 10.1007/s00535-024-02159-y. J Gastroenterol. 2024. PMID: 39432084 Free PMC article. No abstract available.
1,525 results